High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
In conclusion, the high expression of FOXO3 predicts a poor prognosis in patients with HCC, indicating this protein as a potential therapeutic target in HCC.
PMID: 32256814 [PubMed - as supplied by publisher]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology